Rhenman & Partners Asset Management Ab Bio Techne Corp Transaction History
Rhenman & Partners Asset Management Ab
- $766 Million
- Q2 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Bio Techne Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 15,000 shares of TECH stock, worth $963,750. This represents 0.1% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$963,750% of portfolio
0.1%Shares
8 transactions
Others Institutions Holding TECH
# of Institutions
612Shares Held
161MCall Options Held
225KPut Options Held
80.8K-
Vanguard Group Inc Valley Forge, PA18.4MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$963 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.85MShares$568 Million0.05% of portfolio
-
Morgan Stanley New York, NY6.58MShares$423 Million0.02% of portfolio
-
State Street Corp Boston, MA5.86MShares$376 Million0.01% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.52B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...